An update on the safety of breast implants has been reported in the media recently. These reports relate to a rare incidence of breast implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
A very small risk of this disease – an estimated 0.0013% of implant cases worldwide – has been identified. It is important to note that BIA-ALCL is not a form of breast cancer.
The risks of BIA-ALCL forms an important part of discussions our specialist plastic surgeons conduct with every prospective breast augmentation patient at Assure.
All our surgeons are members of the Australian Society of Plastic Surgeons (ASPS) and the Australasian Society of Aesthetic Plastic Surgeons (ASAPS), which have recently published statements as to their members’ commitment in reducing infection risk. A 14-point plan established by Macquarie University, sets a clinical basis for our profession and is a standard our surgeons are strongly committed to.
To read the ASPS and ASAPS statement, including important facts and full details on the rarity and risks of BIA-ALCL, please click here.
Additional information is available from the Australian Government’s Therapeutic Goods Administration, which recently reviewed this issue.
All women with implants who notice changes in their breasts, particularly swelling or hardening, should seek medical advice promptly from their GP or surgeon. The overwhelming majority will not have BIA-ALCL. If you have any concerns and would like to book an appointment with your surgeon at Assure, please click here.
Return to News & Surgeon Blog